Toggle navigation
Home
Psoriasis Models
In Vitro
Psoriasis Models
3D Psoriasis Models
In Vivo
Psoriasis Models
Imiquimod-Induced Psoriasis Models
IL-23-Induced Psoriasis Models
Mannan-Induced Psoriatic Arthritis Models
Zebrafish Psoriasis Models
Drug Discovery
By Drug Modality
Antipsoriatic Small Molecules
Antipsoriatic Therapeutic Antibody
Antipsoriatic Peptides
Nucleic Acid-based Antipsoriatic Therapy
By Target
Cytokine-Targeted Antipsoriatic Drugs
Immune-Targeted Antipsoriatic Drugs
Kinase-Targeted Antipsoriatic Drugs
By Administration Route
Topical Antipsoriatic Drugs
Subcutaneous Antipsoriatic Drugs
Systemic Antipsoriatic Drugs
By Disease
Plaque Psoriasis
Guttate Psoriasis
Erythrodermic Psoriasis
Pustular Psoriasis
Psoriatic Arthritis
Preclinical Drug Development
Dermatopathology Services
Anti-Psoriatic Efficacy Evaluation
Pharmacokinetic Services
Dermatotoxicology Services
Biomarker Discovery
Extracellular Matrix Biomarker Discovery
Omics-Driven Biomarker Discovery
Virtual Booth
Brochure
Animal Models
Company
About Us
Contact Us
Careers
Animal Models
Home
Virtual Booth
Animal Models
Imiquimod-Induced Psoriasis Mouse Models
Imiquimod-Induced NHP Psoriasis Models
